Collegium Pharmaceutical (COLL) Insider Trading & Ownership $37.98 -1.09 (-2.78%) As of 02:30 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Collegium Pharmaceutical (NASDAQ:COLL) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage2.51%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)6Amount OfInsider Selling(Last 12 Months)$5.88M Get COLL Insider Trade Alerts Want to know when executives and insiders are buying or selling Collegium Pharmaceutical stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. COLL Insider Buying and Selling by Quarter Collegium Pharmaceutical Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails8/29/2025Thomas B SmithEVPSell17,478$38.42$671,504.76 8/18/2025Scott DreyerEVPSell16,389$38.21$626,223.69 8/15/2025Gino SantiniDirectorSell5,405$37.19$201,011.95 8/13/2025Scott DreyerEVPSell4,861$38.03$184,863.83 8/8/2025John Gordon FreundDirectorSell11,659$34.36$400,603.24 6/9/2025John Gordon FreundDirectorSell6,601$30.62$202,122.62 3/14/2025Colleen TupperCFOSell977$30.00$29,310.00 3/14/2025Scott DreyerEVPSell2,255$30.00$67,650.00 3/11/2025Colleen TupperCFOSell10,445$30.01$313,454.45 3/6/2025Colleen TupperCFOSell1,949$30.00$58,470.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 3/6/2025Shirley R KuhlmannEVPSell26,067$28.50$742,909.50 3/4/2025Shirley R KuhlmannEVPSell40,000$28.08$1,123,200.00 1/10/2025Shirley R KuhlmannEVPSell27,500$33.04$908,600.00 9/13/2024Thomas B SmithEVPSell9,593$36.62$351,295.66 (Data available from 1/1/2013 forward) COLL Insider Trading Activity - Frequently Asked Questions Who is on Collegium Pharmaceutical's Insider Roster? The list of insiders at Collegium Pharmaceutical includes Colleen Tupper, Garen G Bohlin, Gino Santini, John Gordon Freund, Joseph Ciaffoni, Michael Thomas Heffernan, Scott Dreyer, Shirley R Kuhlmann, and Thomas B Smith. Learn more on insiders at COLL. What percentage of Collegium Pharmaceutical stock is owned by insiders? 2.51% of Collegium Pharmaceutical stock is owned by insiders. Learn more on COLL's insider holdings. Which Collegium Pharmaceutical insiders have been selling company stock? The following insiders have sold COLL shares in the last 24 months: Colleen Tupper ($1,075,513.55), Garen G Bohlin ($936,215.50), Gino Santini ($201,011.95), John Gordon Freund ($602,725.86), Joseph Ciaffoni ($568,281.14), Scott Dreyer ($3,569,556.18), Shirley R Kuhlmann ($4,171,875.90), and Thomas B Smith ($1,022,800.42). How much insider selling is happening at Collegium Pharmaceutical? Insiders have sold a total of 373,962 Collegium Pharmaceutical shares in the last 24 months for a total of $12,147,980.50 sold. Collegium Pharmaceutical Key ExecutivesMr. Michael Thomas Heffernan B.S. Pharm (Age 60)R.Ph., Co-Founder & Chairman Compensation: $110kMr. Joseph J. Ciaffoni (Age 52)President, CEO & Director Compensation: $1.69MMs. Colleen Tupper (Age 48)Executive VP & CFO Compensation: $848.29k1 recent tradesMs. Shirley R. Kuhlmann (Age 40)Executive VP, General Counsel, Chief Administrative Officer & Secretary Compensation: $842.9kMr. Scott Dreyer (Age 52)Executive VP & Chief Commercial Officer Compensation: $746.58k3 recent tradesDr. Thomas B. Smith FAAFP (Age 63)M.D., Executive VP & Chief Medical Officer Compensation: $692.91kDr. Christopher Shayne James M.D.Vice President of Investor RelationsMr. Bart J. DunnExecutive Vice President of Strategy & Corporate DevelopmentMr. Scott SudduthHead of Technical Operations More Insider Trading Tools from MarketBeat Related Companies PTCT Insider Buying KRYS Insider Buying PCVX Insider Buying ACAD Insider Buying ACLX Insider Buying ADMA Insider Buying ARWR Insider Buying MIRM Insider Buying MLTX Insider Buying PTGX Insider Buying Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Sell These High-Quality Stocks: Why Investors Shouldn’tCoreWeave and Madrigal's Insider Trades Flash Bullish SignalsPalantir Insider Selling: Risk Signal or Normal Activity?Loop Industries Insiders Buy Stock, Signal Confidence in OutlookDueling Insider Moves: Heavy Buying Here, Big Selling There This page (NASDAQ:COLL) was last updated on 9/12/2025 by MarketBeat.com Staff From Our PartnersUrgent: $3,452.50 a Month in Passive "AI Equity Checks"The U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredTrump’s Plan May Undo 1933’s Biggest Financial InjusticeTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredGENIUS Act: The Plot to Seize Your Cash?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Collegium Pharmaceutical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Collegium Pharmaceutical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free COLL Stock Alerts